Design and evaluation of folate-appended α-, β-, and γ-Cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo

Biomacromolecules

Volumn 14, Issue 12, 2013, Pages 4420-4428

  Okamatsu, Ayaka ^a   Motoyama, Keiichi ^a   Onodera, Risako ^a   Higashi, Taishi ^a   Koshigoe, Takahiro ^b   Shimada, Yasutaka ^c   Hattori, Kenjiro ^c   Takeuchi, Tomoko ^b   Arima, Hidetoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOKYO POLYTECHNIC UNIVERSITY   (Japan)

^c RandD Lab   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMOR ACTIVITIES; ANTITUMOR DRUGS; BLOOD CHEMISTRY; CELLULAR UPTAKE; DESIGN AND EVALUATIONS; INTRAVENOUS ADMINISTRATION; STABILITY CONSTANTS; TUMOR TARGETING;

CELL CULTURE; CYCLODEXTRINS; MOLECULES; SATURATED FATTY ACIDS;

TUMORS;

ALPHA CYCLODEXTRIN DERIVATIVE; BETA CYCLODEXTRIN DERIVATIVE; DOXORUBICIN; DRUG CARRIER; FLUOROURACIL; FOLATE RECEPTOR 1; FOLIC ACID; GAMMA CYCLODEXTRIN DERIVATIVE; HEXANOIC ACID; PACLITAXEL; VINBLASTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CHEMISTRY; CANCER CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SAFETY; DRUG STABILITY; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CAPROATES; CELL LINE, TUMOR; CYCLODEXTRINS; DOXORUBICIN; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG STABILITY; FLUOROURACIL; FOLATE RECEPTOR 1; FOLIC ACID; HUMANS; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; TUMOR BURDEN;

EID: 84890417467     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm401340g     Document Type: Article

References (50)

1. Wong, H. L.; Bendayan, R.; Rauth, A. M.; Li, Y.; Wu, X. Y. Adv. Drug Delivery Rev. 2007, 59, 491-504
2. Danhier, F.; Feron, O.; Preat, V. J. Controlled Release 2010, 148, 135-46
3. Matsumura, Y.; Maeda, H. Cancer Res. 1986, 46, 6387-92
4. Talekar, M.; Kendall, J.; Denny, W.; Garg, S. Anticancer. Drugs 2011, 22, 949-62
5. Roche, A. C.; Fajac, I.; Grosse, S.; Frison, N.; Rondanino, C.; Mayer, R.; Monsigny, M. Cell. Mol. Life Sci. 2003, 60, 288-97
6. Hatakeyama, H.; Akita, H.; Maruyama, K.; Suhara, T.; Harashima, H. Int. J. Pharm. 2004, 281, 25-33
7. Miyajima, Y.; Nakamura, H.; Kuwata, Y.; Lee, J. D.; Masunaga, S.; Ono, K.; Maruyama, K. Bioconjug. Chem. 2006, 17, 1314-20
8. Harata, M.; Soda, Y.; Tani, K.; Ooi, J.; Takizawa, T.; Chen, M.; Bai, Y.; Izawa, K.; Kobayashi, S.; Tomonari, A.; Nagamura, F.; Takahashi, S.; Uchimaru, K.; Iseki, T.; Tsuji, T.; Takahashi, T. A.; Sugita, K.; Nakazawa, S.; Tojo, A.; Maruyama, K.; Asano, S. Blood 2004, 104, 1442-9
9. Schiffelers, R. M.; Koning, G. A.; ten Hagen, T. L.; Fens, M. H.; Schraa, A. J.; Janssen, A. P.; Kok, R. J.; Molema, G.; Storm, G. J. Controlled Release 2003, 91, 115-22
10. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. Cancer Cell 2009, 16, 510-20
11. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. Science 2010, 328, 1031-5
12. Chen, H.; Ahn, R.; Van Den Bossche, J.; Thompson, D. H.; O'Halloran, T. V. Mol. Cancer Ther. 2009, 8, 1955-63
13. Lu, Y.; Low, P. S. Adv. Drug Delivery Rev. 2002, 54, 675-93
14. Limmon, G. V.; Arredouani, M.; McCann, K. L.; Minor, R. A. C.; Kobzik, L.; Imani, F. FASEB J. 2008, 22, 159-67
15. Ross, J. F.; Chaudhuri, P. K.; Ratnam, M. Cancer 1994, 73, 2432-43
16. Ghaghada, K. B.; Saul, J.; Natarajan, J. V.; Bellamkonda, R. V.; Annapragada, A. V. J. Controlled Release 2005, 104, 113-28
17. Saul, J. M.; Annapragada, A.; Natarajan, J. V.; Bellamkonda, R. V. J. Controlled Release 2003, 92, 49-67
18. Leamon, C. P.; Low, P. S. Drug Discov. Today 2001, 6, 44-51
19. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Anal. Biochem. 2005, 338, 284-93
20. Guo, X.; Shi, C.; Wang, J.; Di, S.; Zhou, S. Biomaterials 2013, 34, 4544-54
21. Watanabe, K.; Kaneko, M.; Maitani, Y. Int. J. Nanomed. 2012, 7, 3679-88
22. Sahoo, B.; Devi, K. S.; Banerjee, R.; Maiti, T. K.; Pramanik, P.; Dhara, D. ACS Appl. Mater. Interfaces 2013, 5, 3884-93
23. Uekama, K.; Hirayama, F.; Irie, T. Chem. Rev. 1998, 98, 2045-76
24. Uekama, K.; Otagiri, M. Crit. Rev. Ther. Drug Carrier Syst. 1987, 3, 1-40
25. Salmaso, S.; Semenzato, A.; Caliceti, P.; Hoebeke, J.; Sonvico, F.; Dubernet, C.; Couvreur, P. Bioconjugate Chem. 2004, 15, 997-1004
26. Caliceti, P.; Salmaso, S.; Semenzato, A.; Carofiglio, T.; Fornasier, R.; Fermeglia, M.; Ferrone, M.; Pricl, S. Bioconjugate Chem. 2003, 14, 899-908
27. Zhang, H.; Cai, Z.; Sun, Y.; Yu, F.; Chen, Y.; Sun, B. J. Biomed. Mater. Res. A 2012, 100, 2441-9
28. Stella, V. J.; He, Q. Toxicol. Pathol. 2008, 36, 30-42
29. Stella, V. J.; Rao, V. M.; Zannou, E. A.; Zia, V. V. Adv. Drug Delivery Rev. 1999, 36, 3-16
30. Ooya, T.; Eguchi, M.; Yui, N. J. Am. Chem. Soc. 2003, 125, 13016-7
31. Ooya, T.; Utsunomiya, H.; Eguchi, M.; Yui, N. Bioconjugate Chem. 2005, 16, 62-9
32. Abe, H.; Kenmoku, A.; Yamaguch, N.; Hattori, K. J. Incl. Phenom. Macrocycl. Chem. 2002, 44, 39-47
33. Hattori, K.; Kenmoku, A.; Mizuguchi, T.; Ikeda, D.; Mizuno, M.; Inazu, T. J. Inclusion Phenom. Macrocyclic Chem. 2006, 56, 9-16
34. Oda, Y.; Kobayashi, N.; Yamanoi, T.; Katsuraya, K.; Takahashi, K.; Hattori, K. Med. Chem. 2008, 4, 244-55
35. Oda, Y.; Yanagisawa, H.; Maruyama, M.; Hattori, K.; Yamanoi, T. Bioorg. Med. Chem. 2008, 16, 8830-40
36. Yamanoi, T.; Yoshida, N.; Oda, Y.; Akaike, E.; Tsutsumida, M.; Kobayashi, N.; Osumi, K.; Yamamoto, K.; Fujita, K.; Takahashi, K.; Hattori, K. Bioorg. Med. Chem. Lett. 2005, 15, 1009-13
37. Okamatsu, A.; Motoyama, K.; Onodera, R.; Higashi, T.; Takahiro, K.; Shimada, Y.; Hattori, K.; Takeuchi, T.; Arima, H. Bioconjugate Chem. 2013, 24, 724-33
38. Job, P. Ann. Chim. 1928, 9, 113-203
39. Scott, R. L. Recl. Trav. Chim. 1956, 75, 787-9
40. Arima, H.; Chihara, Y.; Arizono, M.; Yamashita, S.; Wada, K.; Hirayama, F.; Uekama, K. J. Controlled Release 2006, 116, 64-74
41. Wada, K.; Arima, H.; Tsutsumi, T.; Chihara, Y.; Hattori, K.; Hirayama, F.; Uekama, K. J. Controlled Release 2005, 104, 397-413
42. Hamasaki, K.; Kogure, K.; Ohwada, K. Toxicon 1996, 34, 490-5
43. Ono, N.; Arima, H.; Hirayama, F.; Uekama, K. Biol. Pharm. Bull. 2001, 24, 395-402
44. Yang, J.; Chen, H.; Vlahov, I. R.; Cheng, J. X.; Low, P. S. J. Pharmacol. Exp. Ther. 2007, 321, 462-8
45. Yunomae, K.; Arima, H.; Hirayama, F.; Uekama, K. FEBS Lett. 2003, 536, 225-31
46. Bekers, O.; Van Den Bosch Kettenes, J. J.; Van Helden, S. P.; Seijkens, D.; Beijnen, J. H.; Bulti, A.; Underberg, W. J. M. J. Inclusion Phenom. Mol. Recognit. Chem. 1991, 11, 185-93
47. Wen, J. Q.; Cui, W. Yao Xue Xue Bao 1990, 25, 345-8
48. Chauhan, V. P.; Stylianopoulos, T.; Martin, J. D.; PopoviÄ, Z.; Chen, O.; Kamoun, W. S.; Bawendi, M. G.; Fukumura, D.; Jain, R. K. Nat. Nanotechnol. 2012, 7, 383-8
49. Soliman, H. A.; Olesen, H. Scand. J. Clin. Lab. Invest. 1976, 36, 299-304
50. Antony, A. C. Blood 1992, 79, 2807-20